138 related articles for article (PubMed ID: 19770486)
21. Discrimination of genotoxic from non-genotoxic carcinogens by gene expression profiling.
van Delft JH; van Agen E; van Breda SG; Herwijnen MH; Staal YC; Kleinjans JC
Carcinogenesis; 2004 Jul; 25(7):1265-76. PubMed ID: 14963013
[TBL] [Abstract][Full Text] [Related]
22. Assessing the metabolic competence of sandwich-cultured mouse primary hepatocytes.
Mathijs K; Kienhuis AS; Brauers KJ; Jennen DG; Lahoz A; Kleinjans JC; van Delft JH
Drug Metab Dispos; 2009 Jun; 37(6):1305-11. PubMed ID: 19251822
[TBL] [Abstract][Full Text] [Related]
23. Characterizing and predicting carcinogenicity and mode of action using conventional and toxicogenomics methods.
Waters MD; Jackson M; Lea I
Mutat Res; 2010 Dec; 705(3):184-200. PubMed ID: 20399889
[TBL] [Abstract][Full Text] [Related]
24. Comparative analysis of predictive models for nongenotoxic hepatocarcinogenicity using both toxicogenomics and quantitative structure-activity relationships.
Liu Z; Kelly R; Fang H; Ding D; Tong W
Chem Res Toxicol; 2011 Jul; 24(7):1062-70. PubMed ID: 21627106
[TBL] [Abstract][Full Text] [Related]
25. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
26. Discrimination of genotoxic and non-genotoxic hepatocarcinogens by statistical analysis based on gene expression profiling in the mouse liver as determined by quantitative real-time PCR.
Watanabe T; Suzuki T; Natsume M; Nakajima M; Narumi K; Hamada S; Sakuma T; Koeda A; Oshida K; Miyamoto Y; Maeda A; Hirayama M; Sanada H; Honda H; Ohyama W; Okada E; Fujiishi Y; Sutou S; Tadakuma A; Ishikawa Y; Kido M; Minamiguchi R; Hanahara I; Furihata C
Mutat Res; 2012 Sep; 747(2):164-75. PubMed ID: 22634710
[TBL] [Abstract][Full Text] [Related]
27. Development and evaluation of a genomic signature for the prediction and mechanistic assessment of nongenotoxic hepatocarcinogens in the rat.
Fielden MR; Adai A; Dunn RT; Olaharski A; Searfoss G; Sina J; Aubrecht J; Boitier E; Nioi P; Auerbach S; Jacobson-Kram D; Raghavan N; Yang Y; Kincaid A; Sherlock J; Chen SJ; Car B;
Toxicol Sci; 2011 Nov; 124(1):54-74. PubMed ID: 21813463
[TBL] [Abstract][Full Text] [Related]
28. Expression profile of liver genes in response to hepatotoxicants identified using a SAGE-based customized DNA microarray system.
Inadera H; Tachibana S; Takasaki I; Tabuchi Y; Matsushima K; Uchida M; Shimomura A
Toxicol Lett; 2008 Feb; 177(1):20-30. PubMed ID: 18243596
[TBL] [Abstract][Full Text] [Related]
29. Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity.
Nie AY; McMillian M; Parker JB; Leone A; Bryant S; Yieh L; Bittner A; Nelson J; Carmen A; Wan J; Lord PG
Mol Carcinog; 2006 Dec; 45(12):914-33. PubMed ID: 16921489
[TBL] [Abstract][Full Text] [Related]
30. Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies.
Ellinger-Ziegelbauer H; Gmuender H; Bandenburg A; Ahr HJ
Mutat Res; 2008 Jan; 637(1-2):23-39. PubMed ID: 17689568
[TBL] [Abstract][Full Text] [Related]
31. Modulation of different stress pathways after styrene and styrene-7,8-oxide exposure in HepG2 cell line and normal human hepatocytes.
Diodovich C; Urani C; Maurici D; Malerba I; Melchioretto P; Orlandi M; Zoia L; Campi V; Carfi' M; Pellizzer C; Gribaldo L
J Appl Toxicol; 2006; 26(4):317-25. PubMed ID: 16705669
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay.
Suter W; Ahiabor R; Blanco B; Locher F; Mantovani F; Robinson M; Sreenan G; Staedtler F; Swingler T; Vignutelli A; Perentes E
Environ Mol Mutagen; 1996; 28(4):354-62. PubMed ID: 8991064
[TBL] [Abstract][Full Text] [Related]
33. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
34. Transcriptomic fingerprints in human peripheral blood mononuclear cells indicative of genotoxic and non-genotoxic carcinogenic exposure.
Hochstenbach K; van Leeuwen DM; Gottschalk RW; Gmuender H; Stølevik SB; Nygaard UC; Løvik M; Granum B; Namork E; van Loveren H; van Delft JH
Mutat Res; 2012 Aug; 746(2):124-34. PubMed ID: 22269147
[TBL] [Abstract][Full Text] [Related]
35. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
[TBL] [Abstract][Full Text] [Related]
36. In vivo genotoxic potential of microcystin-LR: a cyanobacterial toxin, investigated both by the unscheduled DNA synthesis (UDS) and the comet assays after intravenous administration.
Gaudin J; Le Hegarat L; Nesslany F; Marzin D; Fessard V
Environ Toxicol; 2009 Apr; 24(2):200-9. PubMed ID: 18561296
[TBL] [Abstract][Full Text] [Related]
37. Prediction of non-genotoxic carcinogenesis in rats using changes in gene expression following acute dosing.
Nioi P; Pardo ID; Sherratt PJ; Snyder RD
Chem Biol Interact; 2008 Apr; 172(3):206-15. PubMed ID: 18328469
[TBL] [Abstract][Full Text] [Related]
38. Application of genomic biomarkers to predict increased lung tumor incidence in 2-year rodent cancer bioassays.
Thomas RS; Pluta L; Yang L; Halsey TA
Toxicol Sci; 2007 May; 97(1):55-64. PubMed ID: 17311802
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profiles in rat liver slices exposed to hepatocarcinogenic enzyme inducers, peroxisome proliferators, and 17alpha-ethinylestradiol.
Werle-Schneider G; Wölfelschneider A; von Brevern MC; Scheel J; Storck T; Müller D; Glöckner R; Bartsch H; Bartelmann M
Int J Toxicol; 2006; 25(5):379-95. PubMed ID: 16940010
[TBL] [Abstract][Full Text] [Related]
40. Differential gene expression profiling between genotoxic and non-genotoxic hepatocarcinogens in young rat liver determined by quantitative real-time PCR and principal component analysis.
Suenaga K; Takasawa H; Watanabe T; Wako Y; Suzuki T; Hamada S; Furihata C
Mutat Res; 2013 Feb; 751(1):73-83. PubMed ID: 23183053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
